Clover Health Investments, Corp. CLOV
Institutional shares held
84.6 Million
4.6M
calls
2.31M
puts
Total value of holdings
$316M
$17.2M
calls
$8.64M
puts
Market Cap
$1.53B
383,248,000
Shares Out.
Institutional ownership
22.08%
# of Institutions
183
We take great care to ensure that the data presented and summarized in this overview for CLOVER HEALTH INVESTMENTS, CORP. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CLOV
View all-
Vanguard Group Inc Valley Forge, PA19.2MShares$76.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny12.5MShares$49.7 Million0.06% of portfolio
-
Black Rock Inc. New York, NY9.54MShares$38 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.83MShares$19.2 Million0.0% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA4.81MShares$19.1 Million0.01% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3MShares$11.9 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X02.76MShares$11 Million0.01% of portfolio
-
State Street Corp Boston, MA2.19MShares$8.71 Million0.0% of portfolio
-
Hudson Structured Capital Management Ltd. Stamford, CT1.97MShares$7.86 Million22.83% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.88MShares$7.48 Million0.0% of portfolio
Latest Institutional Activity in CLOV
Top Purchases
Top Sells
About CLOV
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Insider Transactions at CLOV
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2025
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,670,965
-54.25%
|
$5,012,895
$3.6 P/Share
|
|
Jan 07
2025
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,670,965
+35.17%
|
-
|
|
Jan 07
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
17,142
-0.52%
|
$51,426
$3.6 P/Share
|
|
Jan 07
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,308
-0.31%
|
$12,924
$3.6 P/Share
|
|
Jan 06
2025
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+11.41%
|
-
|
|
Jan 06
2025
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+9.23%
|
-
|
|
Jan 06
2025
|
Thomas L Tran Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+37.72%
|
-
|
|
Jan 06
2025
|
William G Robinson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+10.52%
|
-
|
|
Jan 06
2025
|
Chelsea Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+9.19%
|
-
|
|
Jan 06
2025
|
Lee Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+9.24%
|
-
|
|
Jan 06
2025
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+10.38%
|
-
|
|
Jan 03
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,149
-0.24%
|
$24,447
$3.29 P/Share
|
|
Jan 01
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
278,765
-2.4%
|
$836,295
$3.15 P/Share
|
|
Dec 15
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,691
-0.26%
|
$26,073
$3.11 P/Share
|
|
Dec 15
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,391
-0.46%
|
$19,173
$3.11 P/Share
|
|
Dec 14
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
12,567
-0.37%
|
$37,701
$3.11 P/Share
|
|
Dec 14
2024
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
98,217
-2.83%
|
$294,651
$3.11 P/Share
|
|
Nov 14
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
7,444
-0.53%
|
$22,332
$3.08 P/Share
|
|
Nov 08
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,367
-0.73%
|
$256,101
$3.41 P/Share
|
|
Oct 31
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
152,040
-9.77%
|
$608,160
$4.12 P/Share
|
Last 12 Months Summary
Buy / Acquisition
9.8M
Shares
From
16
Insiders
| Grant, award, or other acquisition | 6.54M shares |
|---|---|
| Exercise of conversion of derivative security | 1.67M shares |
| Open market or private purchase | 1.59M shares |
Sell / Disposition
5.04M
Shares
From
9
Insiders
| Payment of exercise price or tax liability | 4.92M shares |
|---|---|
| Sale (or disposition) back to the issuer | 124K shares |